Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Quest Patent Research (QPRC) EBT (2016 - 2025)

Quest Patent Research (QPRC) has disclosed EBT for 15 consecutive years, with -$5.3 million as the latest value for Q4 2025.

  • Quarterly EBT fell 428.56% to -$5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8.5 million through Dec 2025, down 258.04% year-over-year, with the annual reading at -$8.5 million for FY2025, 258.04% down from the prior year.
  • EBT hit -$5.3 million in Q4 2025 for Quest Patent Research, down from -$1.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $5.2 million in Q4 2023 to a low of -$5.3 million in Q4 2025.
  • Historically, EBT has averaged -$673122.4 across 5 years, with a median of -$643702.5 in 2021.
  • Biggest five-year swings in EBT: skyrocketed 1656.77% in 2021 and later crashed 903.83% in 2023.
  • Year by year, EBT stood at $823008.0 in 2021, then tumbled by 159.38% to -$488735.0 in 2022, then skyrocketed by 1168.22% to $5.2 million in 2023, then tumbled by 119.19% to -$1.0 million in 2024, then tumbled by 428.56% to -$5.3 million in 2025.
  • Business Quant data shows EBT for QPRC at -$5.3 million in Q4 2025, -$1.2 million in Q3 2025, and -$1.1 million in Q2 2025.